A linear model for managing the risk of antimicrobial resistance originating in food animals.

A linear population risk model used by the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) estimates the risk of human cases of campylobacteriosis caused by fluoroquinolone-resistant Campylobacter.

Risk Assessment Model for Human Infection with the Cestode Taenia saginata.

A probabilistic risk assessment model was developed to estimate the risk to human health of Taenia saginata in the New Zealand cattle population. A standardized monitoring program was established to determine the number of suspect cysts detected during postmortem inspection and the scenario set was applied to risks in both the domestic and export markets. The mean number of human infections per year as a result of consumption in the export and the domestic market was estimated as 0.